NASDAQ:CME - Nasdaq - US12572Q1058 - Common Stock - Currency: USD
CME gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 233 industry peers in the Capital Markets industry. While CME has a great profitability rating, there are some minor concerns on its financial health. CME is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 2.27% | ||
ROE | 13.25% | ||
ROIC | 17.02% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 78.35% | ||
PM (TTM) | 35.16% | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.13 | ||
Debt/FCF | 0.91 | ||
Altman-Z | 0.75 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.02 | ||
Quick Ratio | 1.02 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 26.31 | ||
Fwd PE | 23.66 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 26.17 | ||
EV/EBITDA | 12.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.85% |
277.82
+0.29 (+0.1%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.85% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 26.31 | ||
Fwd PE | 23.66 | ||
P/S | 9.83 | ||
P/FCF | 26.17 | ||
P/OCF | 25.58 | ||
P/B | 3.7 | ||
P/tB | N/A | ||
EV/EBITDA | 12.25 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 2.27% | ||
ROE | 13.25% | ||
ROCE | 21.92% | ||
ROIC | 17.02% | ||
ROICexc | 17.76% | ||
ROICexgc | 139.44% | ||
OM | 78.35% | ||
PM (TTM) | 35.16% | ||
GM | N/A | ||
FCFM | 37.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.13 | ||
Debt/FCF | 0.91 | ||
Debt/EBITDA | 0.42 | ||
Cap/Depr | 26.47% | ||
Cap/Sales | 0.87% | ||
Interest Coverage | 61.44 | ||
Cash Conversion | 47.08% | ||
Profit Quality | 106.83% | ||
Current Ratio | 1.02 | ||
Quick Ratio | 1.02 | ||
Altman-Z | 0.75 |